ARRAY BIOPHARMA INC's ticker is and the CUSIP is 04269XAA3. A total of 19 filers reported holding ARRAY BIOPHARMA INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $3,955,000 | +7.3% | 4,600,000 | 0.0% | 0.27% | +20.4% |
| Q1 2016 | $3,685,000 | +29.2% | 4,600,000 | +53.3% | 0.23% | +41.2% |
| Q4 2015 | $2,853,000 | -4.2% | 3,000,000 | 0.0% | 0.16% | +56.9% |
| Q3 2015 | $2,977,000 | -22.2% | 3,000,000 | 0.0% | 0.10% | +75.9% |
| Q2 2015 | $3,825,000 | -66.5% | 3,000,000 | -66.7% | 0.06% | -90.9% |
| Q1 2015 | $11,406,000 | +35.7% | 9,000,000 | 0.0% | 0.64% | +51.2% |
| Q4 2014 | $8,408,000 | +4.8% | 9,000,000 | 0.0% | 0.42% | +1.7% |
| Q3 2014 | $8,025,000 | -11.4% | 9,000,000 | 0.0% | 0.41% | -15.7% |
| Q2 2014 | $9,062,000 | -3.3% | 9,000,000 | 0.0% | 0.49% | -8.8% |
| Q1 2014 | $9,376,000 | -0.6% | 9,000,000 | 0.0% | 0.54% | -2.9% |
| Q4 2013 | $9,428,000 | -10.0% | 9,000,000 | 0.0% | 0.55% | -22.4% |
| Q3 2013 | $10,471,000 | +22.3% | 9,000,000 | 0.0% | 0.71% | +23.8% |
| Q2 2013 | $8,563,000 | – | 9,000,000 | – | 0.58% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|